Frequent <i>SLIT2</i> Promoter Methylation in the Serum of Patients with Ovarian Cancer

Abstract

Hypermethylation of the SLIT2 promoter may be a relatively early event in ovarian cancer; thus, its detection may be an effective approach to improve early diagnosis.